Literature DB >> 33119039

Association Between Aspirin and Cholangiocarcinoma in a Large Asian Cohort.

Min-Hyung Kim1,2, Sang Min Park1, Jooyoung Chang1,3, In Cheol Hwang4.   

Abstract

Entities:  

Year:  2020        PMID： 33119039      PMCID： PMC7596673          DOI： 10.1001/jamaoncol.2020.5018

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Effects of aspirin and non-steroidal anti-inflammatory drugs on the risk of cholangiocarcinoma: a meta-analysis.

Authors:  K Lapumnuaypol; A Tiu; C Thongprayoon; K Wijarnpreecha; P Ungprasert; M A Mao; W Cheungpasitporn
Journal:  QJM       Date:  2019-06-01

2.  Aspirin use and risk of cholangiocarcinoma: External validation with big data.

Authors:  Haider Altaii; Sadeer G Al-Kindi; Guilherme H Oliveira; Zaid Yaqoob; Carlos Romero-Marrero
Journal:  Hepatology       Date:  2017-01-03       Impact factor: 17.425

3.  NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.

Authors:  Jessica L Petrick; Vikrant V Sahasrabuddhe; Andrew T Chan; Michael C Alavanja; Laura E Beane-Freeman; Julie E Buring; Jie Chen; Dawn Q Chong; Neal D Freedman; Charles S Fuchs; John Michael Gaziano; Edward Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lifang Hou; Eric J Jacobs; Lindsay Y King; Jill Koshiol; I-Min Lee; Martha S Linet; Julie R Palmer; Mark P Purdue; Lynn Rosenberg; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Peter T Campbell; Katherine A McGlynn
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-21

4.  Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.

Authors:  Roongruedee Chaiteerakij; Ju Dong Yang; William S Harmsen; Seth W Slettedahl; Teresa A Mettler; Zachary S Fredericksen; W Ray Kim; Gregory J Gores; Rosebud O Roberts; Janet E Olson; Terry M Therneau; Lewis R Roberts
Journal:  Hepatology       Date:  2012-12-12       Impact factor: 17.425

5.  Aspirin use and the risk of cholangiocarcinoma.

Authors:  Jonggi Choi; Hassan M Ghoz; Thoetchai Peeraphatdit; Esha Baichoo; Benyam D Addissie; William S Harmsen; Terry M Therneau; Janet E Olson; Roongruedee Chaiteerakij; Lewis R Roberts
Journal:  Hepatology       Date:  2016-04-26       Impact factor: 17.425

6.  Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer.

Authors:  Min-Hyung Kim; Jooyoung Chang; Warrick Junsuk Kim; Samprit Banerjee; Sang Min Park
Journal:  Am J Gastroenterol       Date:  2018-06-01       Impact factor: 10.864
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.